A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigm

Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2223-2226. doi: 10.1007/s00259-020-04904-w.
No abstract available

Keywords: COVID; FDG-PET; NETest; Neuroendocrine tumor; PPQ; PRRT.

Publication types

  • Editorial
  • Historical Article

MeSH terms

  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy*
  • Coronavirus Infections / transmission
  • Disease Progression
  • Health Services Research
  • History, 21st Century
  • Humans
  • Medical Oncology / standards
  • Neoplasm Metastasis
  • Neuroendocrine Tumors / diagnostic imaging
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / radiotherapy*
  • Octreotide / analogs & derivatives
  • Octreotide / therapeutic use
  • Organometallic Compounds / therapeutic use
  • Pandemics
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / transmission
  • Public Health / history
  • Risk Assessment
  • Severe Acute Respiratory Syndrome / therapy
  • Somatostatin / analogs & derivatives

Substances

  • Organometallic Compounds
  • Somatostatin
  • lutetium Lu 177 dotatate
  • Octreotide